Kalkine Media ASX Share Market News & Research
Watchlist Sign Up/Login
Kalkine Media ASX Share Market News & Research

Immunodiagnostic Systems (LON: IDH) launches SARS-CoV-2 Antigen Rapid Tests

1 min read | November 27, 2020 10:35 AM GMT | By Team Kalkine Media
Google News: https://kalkinemedia.com/resources/assets/public/images/google-news.webp

Recent News

thumbnail

Markets in Focus: What’s Driving the FTSE 100 Today?

thumbnail

Forgent Expands Peak Hills Exploration with Fresh Drilling Activity

thumbnail

Marks Electrical Strengthens Strategy for Sustainable Growth

thumbnail

UK Dividend Calendar: Important Shareholder Events This Week

Make Kalkine Media
My Trusted Source

Google Source

 

Immunodiagnostic Systems Holdings Plc has launched SARS-CoV-2 Antigen Rapid Tests (ART).

  • The two SARS-CoV-2 ART kits offered by the company are now available for sale in the UK, European Union and other countries.
  • Both the tests accept the CE mark as the basis of regulatory approval and can be performed without the need for any laboratory equipment.
  • The two tests are based on the lateral flow principle and are provided by partners of the company.
  • On 27 November 2020, the stocks of the company traded higher by 27.50% from its previous closing, hovering at around GBX 255.00 at 09:58 AM GMT+1.

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Limited, Company No. 12643132 (Kalkine Media, we or us) and is available for personal and non-commercial use only. Kalkine Media is an appointed representative of Kalkine Limited, who is authorized and regulated by the FCA (FRN: 579414). The non-personalised advice given by Kalkine Media through its Content does not in any way endorse or recommend individuals, investment products or services suitable for your personal financial situation. You should discuss your portfolios and the risk tolerance level appropriate for your personal financial situation, with a qualified financial planner and/or adviser. No liability is accepted by Kalkine Media or Kalkine Limited and/or any of its employees/officers, for any investment loss, or any other loss or detriment experienced by you for any investment decision, whether consequent to, or in any way related to this Content, the provision of which is a regulated activity. Kalkine Media does not intend to exclude any liability which is not permitted to be excluded under applicable law or regulation. Some of the Content on this website may be sponsored/non-sponsored, as applicable. However, on the date of publication of any such Content, none of the employees and/or associates of Kalkine Media hold positions in any of the stocks covered by Kalkine Media through its Content. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music/video that may be used in the Content are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music or video used in the Content unless stated otherwise. The images/music/video that may be used in the Content are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

UK_Premium_Article

Sponsored Articles

1

Top 10 FTSE Listed Dividend Paying Stocks

2

KryptoByte and Archax Partner on Custody Framework for Energy-Derived...

3

Union Jack Oil (AIM:UJO) Unlocks Value with New Discoveries and Operat...

4

Union Jack Oil (LON:UJO) reports strong financials for 1H with £2MM ma...

5

A view of how UK’s lottery industry is embracing internet

Investing Ideas

Previous Next